WSTAM
KDNY

Wilbanks Smith & Thomas Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,367
Closed -$344K – 1394
2018
Q3 		$344K Sell
9,367
-7,367
-44% -$271K 0.02% 285
2018
Q2 		$586K Buy
16,734
+10,046
+150% +$352K 0.05% 179
2018
Q1 		$311K Buy
6,688
+1,600
+31% +$74.4K 0.03% 254
2017
Q4 		$191K Buy
+5,088
New +$191K 0.02% 331